Abstract:It is well known that patients with severe facial injuries accompanied by facial disfiguration are vulnerable to a poor quality of life. With the help of facial transplantation, it has become possible to achieve an optimal anatomical reconstruction. As compared to conventional methods, it can provide more desirable functional, aesthetic, and psychosocial outcomes. Face transplantation surgeons need to consider many problems associated with the criteria for selecting patients, techniques for harvesting the dono… Show more
“…Surgical reconstruction involves the transfer from muscle from elsewhere in the body in the form of local flaps or free flaps, but this is limited as muscle is a vital tissue (Boukovalas et al, ; Sahovaler, Yeh, & Yoo, ). Such techniques involve significant donor site morbidity including functional loss and volume deficiency (Eun, ). The use of xenografts and allografts can overcome these limitations, but this approach has risks of immune suppression and transmission of disease (Eun, ).…”
Section: Introductionmentioning
confidence: 99%
“…Such techniques involve significant donor site morbidity including functional loss and volume deficiency (Eun, ). The use of xenografts and allografts can overcome these limitations, but this approach has risks of immune suppression and transmission of disease (Eun, ). Due to these obstacles, material matrices are being developed to restore injured or damaged muscle tissue (Eun, ).…”
Section: Introductionmentioning
confidence: 99%
“…In the field of tissue engineering, several new materials are being developed to replace multiple tissue types including muscle (Eun, ). One type of scaffold that has shown promise to support cell proliferation, differentiation, and migration are decellularized scaffolds (Song & Ott, ).…”
Trauma, congenital diseases, and cancer resection cause muscle deformities of the human facial muscle. Muscle defects are either treated with local or distal flaps if direct closure is not possible. However, such surgical interventions are limited by donor morbidity and limited tissue availability. Decellularized scaffolds provide alternative strategies for replacing and restoring missing facial muscle by creating scaffolds that mimic the native tissue. This study aimed to develop a protocol to decellularize human zygomaticus major muscle (ZMM) and masseter muscle (MM). Three protocols were assessed including a detergent‐only treatment (DOT), detergent‐enzymatic treatment (DET) protocol, and a third nondetergent nonenzymatic treatment protocol. Scaffolds were then characterized via histological, immunofluorescent, and quantitative techniques to assess which protocol provided optimal decellularization and maintenance of the extracellular matrix (ECM). The results demonstrated three cycles of DOT protocol consisting of 2% sodium dodecyl sulfate for 4 hr was optimal for decellularization for both ZMM and MM. After three cycles, DNA content was significantly reduced compared with native ZMM and MM (p < .05) with preservation of collagen and glycosaminoglycan content and ECM on histological analysis. DET and nondetergent nonenzymatic treatment protocols were unsuccessful in decellularizing the ZMM and MM with residual DNA content after four cycles and caused ECM disruption on histological analysis. All protocols did not impair the mechanical properties and supported human fibroblast growth. In conclusion, the DOT protocol is effective in producing human decellularized muscle scaffolds that maintain the ECM. Further investigation of detergent only decellurization techniques should be explored as a first step to create effective scaffolds for muscle tissue engineering.
“…Surgical reconstruction involves the transfer from muscle from elsewhere in the body in the form of local flaps or free flaps, but this is limited as muscle is a vital tissue (Boukovalas et al, ; Sahovaler, Yeh, & Yoo, ). Such techniques involve significant donor site morbidity including functional loss and volume deficiency (Eun, ). The use of xenografts and allografts can overcome these limitations, but this approach has risks of immune suppression and transmission of disease (Eun, ).…”
Section: Introductionmentioning
confidence: 99%
“…Such techniques involve significant donor site morbidity including functional loss and volume deficiency (Eun, ). The use of xenografts and allografts can overcome these limitations, but this approach has risks of immune suppression and transmission of disease (Eun, ). Due to these obstacles, material matrices are being developed to restore injured or damaged muscle tissue (Eun, ).…”
Section: Introductionmentioning
confidence: 99%
“…In the field of tissue engineering, several new materials are being developed to replace multiple tissue types including muscle (Eun, ). One type of scaffold that has shown promise to support cell proliferation, differentiation, and migration are decellularized scaffolds (Song & Ott, ).…”
Trauma, congenital diseases, and cancer resection cause muscle deformities of the human facial muscle. Muscle defects are either treated with local or distal flaps if direct closure is not possible. However, such surgical interventions are limited by donor morbidity and limited tissue availability. Decellularized scaffolds provide alternative strategies for replacing and restoring missing facial muscle by creating scaffolds that mimic the native tissue. This study aimed to develop a protocol to decellularize human zygomaticus major muscle (ZMM) and masseter muscle (MM). Three protocols were assessed including a detergent‐only treatment (DOT), detergent‐enzymatic treatment (DET) protocol, and a third nondetergent nonenzymatic treatment protocol. Scaffolds were then characterized via histological, immunofluorescent, and quantitative techniques to assess which protocol provided optimal decellularization and maintenance of the extracellular matrix (ECM). The results demonstrated three cycles of DOT protocol consisting of 2% sodium dodecyl sulfate for 4 hr was optimal for decellularization for both ZMM and MM. After three cycles, DNA content was significantly reduced compared with native ZMM and MM (p < .05) with preservation of collagen and glycosaminoglycan content and ECM on histological analysis. DET and nondetergent nonenzymatic treatment protocols were unsuccessful in decellularizing the ZMM and MM with residual DNA content after four cycles and caused ECM disruption on histological analysis. All protocols did not impair the mechanical properties and supported human fibroblast growth. In conclusion, the DOT protocol is effective in producing human decellularized muscle scaffolds that maintain the ECM. Further investigation of detergent only decellurization techniques should be explored as a first step to create effective scaffolds for muscle tissue engineering.
“… 11 , 12 Recently, FT has also been regarded as an innovation for treating a severely damaged face. 4 , 13 However, considering the complicated surgical procedures, the need for life-long immunosuppression, the meticulous selection of the patient and the donor body, the unsatisfactory mortality rate, and the ethical controversy, 4 , 13 , 14 FT still must overcome many hurdles before it will gain widespread acceptance. In our case, we proposed a comprehensive strategy that involved DO, a free composite tissue graft, orthodontic treatment, orthognathic surgery, implanted prostheses, and rhinoplasty.…”
Summary:The loss of midface structures always leads to significant functional and cosmetic deficits, and the reconstruction work remains a challenge for surgeons. We report a rare case with severe midfacial defects involving the maxilla, nasal bone, and zygoma. This patient was treated with a comprehensive approach that included distraction osteogenesis, computer-aided surgery, a fibula bone graft, dental implantation, orthognathic surgery, and rhinoplasty. The treatment procedures required 4 years to complete, and a dramatically improved facial contour and stable occlusion were achieved. The results demonstrated the importance of a multidisciplinary approach and computer-aided design when treating severe maxillofacial deformities. Other important elements of the treatment process were the meticulous physical examination, the selection of an optimal treatment sequence, the skill of the surgeons, and more importantly, the patient-oriented mindset.
“…Recently, several great advances have been made in this field and CTA has gained much popularity as a viable alternative reconstructive option. However, CTA has harmful adverse effects of immunosuppressive agents ( 16 , 17 ). Stem cells can contribute to establish life-long tolerance after transplantation avoiding immunosuppressant systemic toxicity.…”
Regenerative medicine using stem cells has progressed significantly over the last decade. Plastic surgeons historically have used tissues of human being to restore various defect sites and utilized a single cell lines for the tissue regeneration. The cell sources (autologous or allogeneic), cell types (embryonic stem cell or adult stem cell), and source of tissues (bone marrow, muscle, adipose, cartilage, or blood) are very important for stem cell-based tissue coverage. Embryonic stem cells are pluripotent precursors obtained from the inner cell mass of the blastocyst and reported to be used for preventing muscle atrophy after peripheral nerve injury. Multipotent adult stem cells are easily accessed for plastic surgeons during many routine procedures. This article briefly review the current state of overall stem cell research and clinical applications in the plastic surgical field.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.